Literature DB >> 9597258

Prevalence of intestinal encephalitozoonosis in Mexico.

F J Enriquez1, D Taren, A Cruz-López, M Muramoto, J D Palting, P Cruz.   

Abstract

Infections with Encephalitozoon (phylum Microspora) protozoa in immunodeficient patients have emerged worldwide. The prevalence of infections due to Encephalitozoon species in nonclinical populations remains unclear. We conducted a cross-sectional survey of two rural highland villages in Mexico by using monoclonal antibody 3B6 to Encephalitozoon in immunofluorescence to assess the prevalence of Encephalitozoon spores in human stools. We found that 20 (7.84%) of the 255 subjects were positive and that 15 (21.4%) of the 70 households had at least one member who was positive. These results suggest that Encephalitozoon species, most likely Encephalitozoon intestinalis, may be commonly present in community settings.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9597258     DOI: 10.1086/520278

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

1.  Genetic homology among thirteen Encephalitozoon intestinalis isolates obtained from human immunodeficiency virus-infected patients with intestinal microsporidiosis.

Authors:  O Liguory; S Fournier; C Sarfati; F Derouin; J M Molina
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  One-step purification of Enterocytozoon bieneusi spores from human stools by immunoaffinity expanded-bed adsorption.

Authors:  I Accoceberry; M Thellier; A Datry; I Desportes-Livage; S Biligui; M Danis; X Santarelli
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Quantitative assessment of contamination of fresh food produce of various retail types by human-virulent microsporidian spores.

Authors:  Szymon Jedrzejewski; Thaddeus K Graczyk; Anna Slodkowicz-Kowalska; Leena Tamang; Anna C Majewska
Journal:  Appl Environ Microbiol       Date:  2007-04-20       Impact factor: 4.792

4.  Carbohydrate moieties of microsporidian polar tube proteins are targeted by immunoglobulin G in immunocompetent individuals.

Authors:  Ron Peek; Frédéric Delbac; Dave Speijer; Valérie Polonais; Sophie Greve; Ellen Wentink-Bonnema; Jeffrey Ringrose; Tom van Gool
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  A spore counting method and cell culture model for chlorine disinfection studies of Encephalitozoon syn. Septata intestinalis.

Authors:  D M Wolk; C H Johnson; E W Rice; M M Marshall; K F Grahn; C B Plummer; C R Sterling
Journal:  Appl Environ Microbiol       Date:  2000-04       Impact factor: 4.792

Review 6.  A review of the development of two types of human skeletal muscle infections from microsporidia associated with pathology in invertebrates and cold-blooded vertebrates.

Authors:  Ann Cali; Louis M Weiss; Peter M Takvorian
Journal:  Folia Parasitol (Praha)       Date:  2005-05       Impact factor: 2.122

7.  Microsporidian species known to infect humans are present in aquatic birds: implications for transmission via water?

Authors:  Anna Slodkowicz-Kowalska; Thaddeus K Graczyk; Leena Tamang; Szymon Jedrzejewski; Andrzej Nowosad; Piotr Zduniak; Piotr Solarczyk; Autumn S Girouard; Anna C Majewska
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

8.  Municipal wastewater treatment plants as removal systems and environmental sources of human-virulent microsporidian spores.

Authors:  Hui-Wen A Cheng; Frances E Lucy; Thaddeus K Graczyk; Michael A Broaders; Sergey E Mastitsky
Journal:  Parasitol Res       Date:  2011-03-01       Impact factor: 2.289

Review 9.  Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia.

Authors:  C Franzen; A Müller
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

10.  Quantitative evaluation of the impact of bather density on levels of human-virulent microsporidian spores in recreational water.

Authors:  Thaddeus K Graczyk; Deirdre Sunderland; Leena Tamang; Timothy M Shields; Frances E Lucy; Patrick N Breysse
Journal:  Appl Environ Microbiol       Date:  2007-05-04       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.